{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-079677","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2023-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.157315+00:00","generated_at":"2026-06-10T08:10:07.174658+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Adial recasts 2022 and 2021 financials to reflect Purnovate discontinued ops after sale","bullets":["Completed sale of Purnovate assets and business to Adovate, LLC on June 30, 2023.","Historical Purnovate results now shown as discontinued operations for 2022 and 2021.","Only Item 7 (MD&A) and Item 8 (Financial Statements) are revised; other 10-K sections unchanged.","Company directs investors to Q1 and Q2 2023 Form 10-Qs for more recent developments."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-079677","json":"https://secwatch.observer/filing/0001213900-23-079677.json","markdown":"https://secwatch.observer/filing/0001213900-23-079677.md","text":"https://secwatch.observer/filing/0001213900-23-079677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023079677/0001213900-23-079677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023079677/ea185608-8k_adialpharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T08:10:07.174658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}